What are AnaptysBio's total assets?

AnaptysBio reported total assets of $316.98M as of Jun 30, 2026, down 13.0% from $364.39M a year earlier. Total liabilities were $306.40M.

What is AnaptysBio's shareholders' equity?

AnaptysBio's shareholders' equity was $10.59M as of Jun 30, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

AnaptysBio (ANAB) Balance Sheet: Assets & Liabilities

AnaptysBio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for AnaptysBio, Inc. (ANAB) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	133.83	238.20	23.08	35.97	71.31	495.73	250.46	171.02	113.60	81.19
Short-Term Investments	30.32	73.44	262.29	354.94	369.93	52.37	143.20	203.21	313.49	167.22
Cash & Short-Term Investments	164.14	311.64	285.37	390.90	441.24	548.10	393.65	374.23	427.08	248.41
Accounts Receivable	-	33.85	40.77	6.85	1.42	0.88	0.00	0.00	0.17	1.60
Inventory	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	-	4.76	1.18	9.08	4.55	4.90	2.91	3.51	6.96	2.69
Total Current Assets	198.43	350.25	431.88	406.84	447.21	553.88	396.56	377.73	434.22	252.70
Non-Current Assets
Property, Plant & Equipment (Net)	-	13.89	14.51	18.27	19.99	21.84	2.13	1.62	1.45	0.67
Long-Term Investments	-	0.00	35.47	27.03	142.94	67.10	17.55	54.31	73.13	75.90
Other Non-Current Assets	-	0.26	1.97	0.26	0.26	0.26	0.32	1.54	0.21	0.11
Total Non-Current Assets	-	14.15	51.96	45.55	163.18	89.19	19.99	57.46	74.78	76.67
Total Assets	316.98	364.40	483.83	452.39	610.38	643.07	416.55	435.20	509.00	329.36
Current Liabilities
Accounts Payable	-	3.87	4.00	4.70	2.78	1.74	4.22	16.24	5.44	2.32
Short-Term Debt	-	2.08	1.93	1.78	1.64	1.51	0.34	2.25	7.63	6.89
Accrued Liabilities	-	32.67	31.05	23.77	16.25	12.85	15.26	-	-	-
Deferred Revenue	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.70	4.86
Other Current Liabilities	-	32.67	39.50	0.46	21.63	12.85	15.26	11.05	8.76	4.88
Total Current Liabilities	-	38.63	45.43	37.44	26.05	16.10	19.82	29.54	21.84	14.09
Non-Current Liabilities
Long-Term Debt	-	12.03	14.11	16.04	17.81	19.45	0.00	0.65	0.63	7.55
Deferred Tax Liabilities	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.17	-0.14
Other Non-Current Liabilities	-	276.53	353.43	310.81	304.41	251.09	0.00	0.00	0.17	0.14
Total Non-Current Liabilities	-	288.56	367.54	326.84	322.23	270.54	0.00	0.65	0.80	7.69
Total Liabilities	306.40	327.19	412.97	364.29	348.28	286.64	19.82	30.19	22.63	21.78
Stockholders' Equity
Common Stock	-	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02
Retained Earnings	-	-772.56	-759.33	-614.10	-450.48	-321.75	-263.96	-244.03	-146.69	-85.03
Accumulated Other Comprehensive Income	-	-0.02	0.31	-0.80	-5.25	-0.42	0.00	0.34	-0.22	-0.43
Additional Paid-in Capital	-	809.77	829.86	702.97	717.80	678.58	660.67	648.67	633.25	393.02
Shares Outstanding	-	28.02	30.47	26.60	28.51	27.65	-	-	-	-
Total Stockholders' Equity	10.59	37.21	70.87	88.10	262.10	356.43	396.73	405.01	486.37	307.58
Total Liabilities & Equity	-	364.40	483.83	452.39	610.38	643.07	416.55	435.20	509.00	329.36

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

AnaptysBio Balance Sheet Analysis

Frequently Asked Questions About AnaptysBio Balance Sheet